News Presentations Publications

FILTERS

TOPICS

DFB Pharmaceuticals, CritiTech, and US Biotest Form NanOlogy™ for Clinical Development of Naked Nanoparticle Platform to Treat Cancer and Related Illnesses

September 12, 2017 05:30 AM Eastern Daylight Time FORT WORTH, Texas–(BUSINESS WIRE)–DFB Pharmaceuticals, a private investment and development group, in … Continued

More >